INVESTOR

INVESTOR SELECTED COMPANIES

In 2017, 19 startup companies were selected to present at the BIOVISION INVESTOR. Recognized based on a set of criteria including youth, performance, ambition and appeal to civil society, these companies illustrate the dynamics of the Life Sciences sector in Europe.




INVESTOR 2017 selected Companies

 
Valerie SCAPPATICCI

Aelis Farma

Signaling Specific Inhibitors, a unique approach to address CB1 dependent diseases: the first therapy of cannabis use disorder,a new pharmacological approach for CB1-dependent Intellectual Disabilities

Emmanuel VINCENT

Aenitis Technologies

Aenitis develop a revolution in labile blood products sorting solutions based on acoustophoresis to avoid centrifuge steps constrains.

 
Benoit VETTIER

Cartimage Medical

Imaging for Conversative Surgery

Cedric VERVERKEN

Confo Therapeutics

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

 
Alexis MATHIEU

FeetMe

FeetMe assess gait remotely and retrain through personal coaching with a simple connected wearable device. A connected insole.

Omar F. Zouani

Histide

Innovative extracellular non-mutagenic technologies for tissue healing and regeneration.

 
Paul MICHALET

IDD BIOTECH

Beyond Targets : Epitopes & MAb designs - IDDB develops a large innovative pipeline of monoclonal antibodies for Oncology and immune deseases

Frédéric LEDUC

Immune Biosolutions

An innovative biotech company focused on the discovery and engineering of chicken antibodies that target difficult proteins with a validated, yet unexploited, therapeutic potential.

 
Clark TEDFORD

LumiThera

LumiThera is a developing a non-invasive treatment to prevent vision loss in patients with degenerative eye disease

Jean-Yves QUENTEL

Mensia Therapeutics

Mensia Koala is a home-based, non-invasive medical device for the care of ADHD.

 
Rudolf SCHULZE VOHREN

NANO4IMAGING

Exceptional Opportunity in Cardiovascular Devices

Pascal VOISIN

Neurophoenix

A new therapeutic approach to neurodegenerative diseases

 
Benjamin HADIDA

Nextbiotix

Nextbiotix is the next-generation probiotics company

Bruno LAFONT

NFL-101

The only product immediately and safely reducing cigarette appetence, leading to more efficient smoking cessation therapies.

 
Géraldine LE DUC

NH TherAguix

A clinical stage pharmaceutical company developing AGuIX®, an innovative nanomedicine that improves radiation therapy benefits without modifying current clinical workflows.

Didier NIMAL

OSSEOMATRIX

OsseoMatrix improves the treatment of bone defects with custom designed synthetic bones produced through a proprietary 3D printing process and substrates for bioengineering

 
Jeremie Blache

Pili

Biosourced and competitive colors without petrochemistry nor pesticides.

Michel FERAUD

Provepharm

A pioneer in the development and commercialization of innovative pharmaceutical solutions thanks to its chemical and peptide know-how and its proven business model.

 
Eduard DIVIU

Sagetis Biotech

Systemic adenovirotherapy for the treatment of pancreatic ductal adenocarcinoma

Geoffroy DE RIBAINS

Step Pharma

Development of a new class of oral immunomodulators for the treatment of autoimmune diseases and cancer

 
Pascal SCHWEIZER

Thermosome

Novel tumor targeting approach for locally-advanced solid tumors in neoadjuvant settings and beyond by up to 15 fold higher local drug concentrations and simultaneously reduced systemic side effects, thereby markedly improving the drug’s therapeutic index.

 


More About INVESTOR